Overexpression of BIRC6 Is a Predictor of Prognosis for Colorectal Cancer.

Inhibitors of apoptosis proteins (IAPs) have been well investigated in human cancers, where they are frequently overexpressed and associated with poor prognosis. Here we explored the role of baculoviral IAP repeat containing 6 (BIRC6), a member of IAPs, in human colorectal cancer (CRC).We used Weste...

Full description

Bibliographic Details
Main Authors: Tingting Hu, Shuqiang Weng, Wenqing Tang, Ruyi Xue, She Chen, Guoxiang Cai, Yu Cai, Xizhong Shen, Si Zhang, Ling Dong
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4416929?pdf=render
_version_ 1818943722108223488
author Tingting Hu
Shuqiang Weng
Wenqing Tang
Ruyi Xue
She Chen
Guoxiang Cai
Yu Cai
Xizhong Shen
Si Zhang
Ling Dong
author_facet Tingting Hu
Shuqiang Weng
Wenqing Tang
Ruyi Xue
She Chen
Guoxiang Cai
Yu Cai
Xizhong Shen
Si Zhang
Ling Dong
author_sort Tingting Hu
collection DOAJ
description Inhibitors of apoptosis proteins (IAPs) have been well investigated in human cancers, where they are frequently overexpressed and associated with poor prognosis. Here we explored the role of baculoviral IAP repeat containing 6 (BIRC6), a member of IAPs, in human colorectal cancer (CRC).We used Western blotting and immunohistochemistry to examine BIRC6 expression in 7 CRC cell lines and 126 CRC clinical samples. We determined the biological significance of BIRC6 in CRC cell lines by a lentivirus-mediated silencing method.We reported that BIRC6 was overexpressed in CRC cell lines and clinical CRC tissues. BIRC6 overexpression was correlated with tumor size and invasion depth of CRC. BIRC6 overexpression is associated with worse overall survival (OS) (P = 0.001) and shorter disease-free survival (DFS) (P = 0.010). BIRC6 knockdown inhibited cell proliferation, arrested cell cycle at S phase, downregulated cyclin A2, B1, D1 and E1 levels, and sensitized CRC cells to chemotherapy in vitro and in vivo.Taken together, these data suggests that BIRC6 overexpression is a predictor of poor prognosis in colorectal cancer and BIRC6 could be a potential target of CRC therapy.
first_indexed 2024-12-20T07:31:50Z
format Article
id doaj.art-06ecb33ddaad4fff85a74584e7b9e221
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-20T07:31:50Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-06ecb33ddaad4fff85a74584e7b9e2212022-12-21T19:48:24ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01105e012528110.1371/journal.pone.0125281Overexpression of BIRC6 Is a Predictor of Prognosis for Colorectal Cancer.Tingting HuShuqiang WengWenqing TangRuyi XueShe ChenGuoxiang CaiYu CaiXizhong ShenSi ZhangLing DongInhibitors of apoptosis proteins (IAPs) have been well investigated in human cancers, where they are frequently overexpressed and associated with poor prognosis. Here we explored the role of baculoviral IAP repeat containing 6 (BIRC6), a member of IAPs, in human colorectal cancer (CRC).We used Western blotting and immunohistochemistry to examine BIRC6 expression in 7 CRC cell lines and 126 CRC clinical samples. We determined the biological significance of BIRC6 in CRC cell lines by a lentivirus-mediated silencing method.We reported that BIRC6 was overexpressed in CRC cell lines and clinical CRC tissues. BIRC6 overexpression was correlated with tumor size and invasion depth of CRC. BIRC6 overexpression is associated with worse overall survival (OS) (P = 0.001) and shorter disease-free survival (DFS) (P = 0.010). BIRC6 knockdown inhibited cell proliferation, arrested cell cycle at S phase, downregulated cyclin A2, B1, D1 and E1 levels, and sensitized CRC cells to chemotherapy in vitro and in vivo.Taken together, these data suggests that BIRC6 overexpression is a predictor of poor prognosis in colorectal cancer and BIRC6 could be a potential target of CRC therapy.http://europepmc.org/articles/PMC4416929?pdf=render
spellingShingle Tingting Hu
Shuqiang Weng
Wenqing Tang
Ruyi Xue
She Chen
Guoxiang Cai
Yu Cai
Xizhong Shen
Si Zhang
Ling Dong
Overexpression of BIRC6 Is a Predictor of Prognosis for Colorectal Cancer.
PLoS ONE
title Overexpression of BIRC6 Is a Predictor of Prognosis for Colorectal Cancer.
title_full Overexpression of BIRC6 Is a Predictor of Prognosis for Colorectal Cancer.
title_fullStr Overexpression of BIRC6 Is a Predictor of Prognosis for Colorectal Cancer.
title_full_unstemmed Overexpression of BIRC6 Is a Predictor of Prognosis for Colorectal Cancer.
title_short Overexpression of BIRC6 Is a Predictor of Prognosis for Colorectal Cancer.
title_sort overexpression of birc6 is a predictor of prognosis for colorectal cancer
url http://europepmc.org/articles/PMC4416929?pdf=render
work_keys_str_mv AT tingtinghu overexpressionofbirc6isapredictorofprognosisforcolorectalcancer
AT shuqiangweng overexpressionofbirc6isapredictorofprognosisforcolorectalcancer
AT wenqingtang overexpressionofbirc6isapredictorofprognosisforcolorectalcancer
AT ruyixue overexpressionofbirc6isapredictorofprognosisforcolorectalcancer
AT shechen overexpressionofbirc6isapredictorofprognosisforcolorectalcancer
AT guoxiangcai overexpressionofbirc6isapredictorofprognosisforcolorectalcancer
AT yucai overexpressionofbirc6isapredictorofprognosisforcolorectalcancer
AT xizhongshen overexpressionofbirc6isapredictorofprognosisforcolorectalcancer
AT sizhang overexpressionofbirc6isapredictorofprognosisforcolorectalcancer
AT lingdong overexpressionofbirc6isapredictorofprognosisforcolorectalcancer